Wang Hongwei, Qi Songtao, Dou Changwu, Ju Haitao, He Zhanbiao, Ma Qinghai
Department of Neurosurgery, Nanfang Hospital Southern Medical University, Guangzhou, Guangdong 510515, P.R. China.
Department of Neurosurgery, Affiliated Hospital of Inner Mongolia Medical College, Hohhot, Inner Mongolia 010050, P.R. China.
Oncol Lett. 2016 Jul;12(1):343-347. doi: 10.3892/ol.2016.4603. Epub 2016 May 18.
In the present study, the efficacy and clinical outcomes of stereotactic aspiration combined with the Gamma Knife radiosurgery (GKRS) method were evaluated retrospectively for patients with large cystic brain metastases. This combined method aims to decrease the tumor weight (volume) and increase the possible radiation dose. The present study involved 48 patients who were diagnosed with cystic metastatic brain tumors between January 2008 and December 2012 in the Department of Neurosurgery of Nanfang Hospital Southern Medical University (Guangzhou, China). Every patient underwent Leksell stereotactic frame, 1.5T magnetic resonance imaging (MRI)-guided stereotactic cyst aspiration and Leksell GKRS. Subsequent to the therapy, MRI was performed every 3 months. The results indicated that 48 cases were followed up for 24-72 months, with a mean follow-up duration of 36.2 months. Following treatment, 44 patients (91.7%) exhibited tumor control and 4 patients (8.3%) experienced progression of the local tumor. During this period, 35 patients (72.9%) succumbed, but only 2 (4.2%) of these succumbed to the brain metastases. The total local control rate was 91.7% and the median overall survival time of all patients was 19.5 months. The 1-year overall survival rate was 70.8% and the 2-year overall survival rate was 26.2%. In conclusion, these results indicated that the method of stereotactic cyst aspiration combined with GKRS was safe and effective for patients with large cystic brain metastases. This method is effective for patients whose condition is too weak for general anesthesia and in whom the tumors are positioned at eloquent areas. This method enables patients to avoid a craniotomy, and provides a good tumor control rate, survival time and quality of life.
在本研究中,我们对立体定向穿刺抽吸联合伽玛刀放射外科治疗(GKRS)方法用于大型囊性脑转移瘤患者的疗效和临床结果进行了回顾性评估。这种联合方法旨在减轻肿瘤重量(体积)并增加可能的放射剂量。本研究纳入了2008年1月至2012年12月期间在南方医科大学南方医院神经外科(中国广州)被诊断为囊性转移性脑肿瘤的48例患者。每位患者均接受了Leksell立体定向框架、1.5T磁共振成像(MRI)引导下的立体定向囊肿抽吸以及Leksell GKRS。治疗后,每3个月进行一次MRI检查。结果显示,48例患者随访了24 - 72个月,平均随访时间为36.2个月。治疗后,44例患者(91.7%)实现了肿瘤控制,4例患者(8.3%)出现局部肿瘤进展。在此期间,35例患者(72.9%)死亡,但其中只有2例(4.2%)死于脑转移。总局部控制率为91.7%,所有患者的中位总生存时间为19.5个月。1年总生存率为70.8%,2年总生存率为26.2%。总之,这些结果表明,立体定向囊肿抽吸联合GKRS方法对于大型囊性脑转移瘤患者是安全有效的。该方法对于因身体过于虚弱而无法进行全身麻醉且肿瘤位于功能区的患者有效。这种方法使患者避免了开颅手术,并提供了良好的肿瘤控制率、生存时间和生活质量。